VAXIMM AG

📍 Basel, Switzerland🗓 Founded 2008👥 3 employees💰 Last funded Jul 2019
Biotechnology Research🌐 vaximm.com
Website LinkedIn
VAXIMM is a privately held, Swiss/German biotech company that is developing oral T-cell immunotherapies for patients suffering from cancer. VAXIMM’s product platform is based on a live attenuated, safe, orally available bacterial vaccine strain, which is modified to stimulate patients’ cytotoxic T-cells to target specific structures of the tumor. The Company has a pipeline of complementary development candidates targeting different tumor structures. Lead product candidate, oral VXM01, activates killer cells targeting tumor-specific vasculature and certain immune-suppressive cells, thereby increasing immune cell infiltration in solid tumors. VXM01 is currently in clinical development for several tumor types, including brain cancer. VAXIMM has completed a clinical trial evaluating VXM01 in combination with the human anti-PD-L1 antibody, avelumab, as part of a scientific collaboration with Merck KGaA, Darmstadt, Germany. VAXIMM also has a collaboration agreement with China Medical System Holdings (CMS), granting CMS full rights in China and other Asian countries (excluding Japan) to VAXIMM’s existing programs. VAXIMM AG is headquartered in Basel, Switzerland. Its wholly owned subsidiary, VAXIMM GmbH, located in Mannheim, Germany, is responsible for the Company’s development activities.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
1
Netherlands
1
Denmark
1
Investor activity2017–2019 · investors recorded per year
201712018120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VAXIMM AG?
VAXIMM AG has 3 investors on record on gritt.io and 2 late-stage investors.
When did VAXIMM AG last raise funding?
The most recent investment in VAXIMM AG recorded on gritt.io was in July 2019.
When was VAXIMM AG founded?
VAXIMM AG was founded in 2008.
What industry is VAXIMM AG in?
VAXIMM AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VAXIMM AG based?
VAXIMM AG is headquartered in Basel, Switzerland.